| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | ARID1B TCERG1L PER2 NUP98 SSX9P SSX7 SSX8P BCL11A NCOA4 SSX1 SSX3 | 3.99e-05 | 562 | 89 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NOLC1 ARID1B TCERG1L PER2 NUP98 SSX9P SSX7 SSX8P SH2D2A BCL11A NCOA4 SSX1 WNK1 SSX3 RBM47 AKAP12 | 4.82e-05 | 1160 | 89 | 16 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription factor binding | NOLC1 MSX2 TAF3 AKAP8 PER2 PCLO RBPJ BCL11A TAF1 REST TAF1L BHLHE40 | 1.25e-04 | 753 | 89 | 12 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II core promoter sequence-specific DNA binding | 1.83e-04 | 25 | 89 | 3 | GO:0000979 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 1.95e-04 | 5 | 89 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 2.32e-04 | 27 | 89 | 3 | GO:0001091 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | NOLC1 ARID1B TCERG1L PER2 NUP98 SSX9P SSX7 SSX8P SH2D2A BCL11A NCOA4 SSX1 WNK1 SSX3 RBM47 AKAP12 | 2.95e-04 | 1356 | 89 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 5.49e-04 | 36 | 89 | 3 | GO:0140416 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 5.60e-04 | 229 | 89 | 6 | GO:0003714 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 6.93e-04 | 9 | 89 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 1.35e-03 | 596 | 89 | 9 | GO:0140678 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.53e-03 | 51 | 89 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor activity | 1.62e-03 | 52 | 89 | 3 | GO:0016251 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.65e-03 | 739 | 89 | 10 | GO:0003682 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 1.90e-03 | 55 | 89 | 3 | GO:0001046 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.90e-03 | 55 | 89 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.44e-03 | 60 | 89 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.61e-03 | 417 | 89 | 7 | GO:0061629 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 2.93e-03 | 64 | 89 | 3 | GO:0140296 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 3.20e-03 | 66 | 89 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 3.20e-03 | 66 | 89 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | general transcription initiation factor activity | 3.48e-03 | 68 | 89 | 3 | GO:0140223 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 4.43e-03 | 582 | 89 | 8 | GO:0140297 | |
| GeneOntologyBiologicalProcess | RNA splicing | RBM19 AHNAK ZCRB1 NUP98 RBM42 NCL REST MTREX IK RBM47 AHNAK2 | 8.40e-06 | 502 | 87 | 11 | GO:0008380 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 2.02e-05 | 358 | 87 | 9 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.02e-05 | 358 | 87 | 9 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 2.20e-05 | 362 | 87 | 9 | GO:0000375 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 2.74e-05 | 207 | 87 | 7 | GO:0043484 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription regulatory region DNA binding | 3.90e-05 | 16 | 87 | 3 | GO:2000678 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 5.56e-05 | 158 | 87 | 6 | GO:0050684 | |
| GeneOntologyBiologicalProcess | mRNA processing | 1.08e-04 | 551 | 87 | 10 | GO:0006397 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | TAF3 RBM19 ZCRB1 NUP98 RBM42 LARP1 NCL TAF1 CDK11B REST MTREX IK RBM47 | 1.18e-04 | 917 | 87 | 13 | GO:0016071 |
| GeneOntologyBiologicalProcess | RNA processing | NOLC1 REXO4 RBM19 AHNAK U2SURP ZCRB1 WDR46 NUP98 RPS15 RBM42 NCL CDK11B REST MTREX IK RBM47 AHNAK2 | 1.53e-04 | 1500 | 87 | 17 | GO:0006396 |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 2.17e-04 | 129 | 87 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | axonemal central apparatus assembly | 2.61e-04 | 6 | 87 | 2 | GO:1904158 | |
| GeneOntologyBiologicalProcess | regulation of termination of DNA-templated transcription | 2.61e-04 | 6 | 87 | 2 | GO:0031554 | |
| GeneOntologyCellularComponent | sperm flagellum | 3.36e-05 | 214 | 88 | 7 | GO:0036126 | |
| GeneOntologyCellularComponent | rod spherule | 5.24e-05 | 3 | 88 | 2 | GO:0044317 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 6.59e-05 | 238 | 88 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | nuclear body | NOLC1 MSX2 REXO4 AMER1 RBBP6 RBM19 SCN1A MORF4L1 NUP98 BCL11A MTREX IK BHLHE40 | 9.98e-05 | 903 | 88 | 13 | GO:0016604 |
| GeneOntologyCellularComponent | motile cilium | 1.26e-04 | 355 | 88 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | cone cell pedicle | 1.74e-04 | 5 | 88 | 2 | GO:0044316 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NOLC1 ARID1B TAF3 PER2 CTC1 MORF4L1 ZCRB1 NUP98 RBM42 NCL BCL11A TAF1 MTREX IK RBM47 TAF1L | 1.83e-04 | 1377 | 88 | 16 | GO:0140513 |
| GeneOntologyCellularComponent | pronucleus | 2.19e-04 | 28 | 88 | 3 | GO:0045120 | |
| GeneOntologyCellularComponent | axonemal central apparatus | 2.60e-04 | 6 | 88 | 2 | GO:1990716 | |
| GeneOntologyCellularComponent | cilium | KIFAP3 EYS MAP4 SPEF2 AK2 SSX9P SSX7 SSX8P SPAG17 SSX1 SSX3 HYDIN | 3.73e-04 | 898 | 88 | 12 | GO:0005929 |
| GeneOntologyCellularComponent | transcription factor TFIID complex | 1.02e-03 | 47 | 88 | 3 | GO:0005669 | |
| GeneOntologyCellularComponent | mitotic spindle | 1.61e-03 | 201 | 88 | 5 | GO:0072686 | |
| Domain | KRAB_RELATED | 3.89e-12 | 11 | 87 | 6 | PS50806 | |
| Domain | Krueppel-associated_box-rel | 1.43e-11 | 13 | 87 | 6 | IPR003655 | |
| Domain | SSX | 6.54e-09 | 6 | 87 | 4 | IPR028804 | |
| Domain | SSXRD | 3.03e-08 | 8 | 87 | 4 | PF09514 | |
| Domain | SSXRD_motif | 3.03e-08 | 8 | 87 | 4 | IPR019041 | |
| Domain | TAF_II_230-bd | 2.14e-05 | 2 | 87 | 2 | IPR009067 | |
| Domain | TFIID_sub1_DUF3591 | 2.14e-05 | 2 | 87 | 2 | IPR022591 | |
| Domain | - | 2.14e-05 | 2 | 87 | 2 | 1.10.1100.10 | |
| Domain | TBP-binding | 2.14e-05 | 2 | 87 | 2 | PF09247 | |
| Domain | DUF3591 | 2.14e-05 | 2 | 87 | 2 | PF12157 | |
| Domain | TAF1_animal | 2.14e-05 | 2 | 87 | 2 | IPR011177 | |
| Domain | RRM_1 | 5.28e-05 | 208 | 87 | 7 | PF00076 | |
| Domain | RRM | 6.90e-05 | 217 | 87 | 7 | SM00360 | |
| Domain | RRM_dom | 9.15e-05 | 227 | 87 | 7 | IPR000504 | |
| Domain | RRM | 9.93e-05 | 230 | 87 | 7 | PS50102 | |
| Domain | - | 1.43e-04 | 244 | 87 | 7 | 3.30.70.330 | |
| Domain | RRM_dom_euk | 1.62e-04 | 23 | 87 | 3 | IPR003954 | |
| Domain | RRM_1 | 1.62e-04 | 23 | 87 | 3 | SM00361 | |
| Domain | Nucleotide-bd_a/b_plait | 2.02e-04 | 258 | 87 | 7 | IPR012677 | |
| Domain | PDZ | 7.01e-04 | 151 | 87 | 5 | PS50106 | |
| Domain | PDZ | 7.22e-04 | 152 | 87 | 5 | IPR001478 | |
| Domain | Adenylat/UMP-CMP_kin | 9.42e-04 | 10 | 87 | 2 | IPR000850 | |
| Domain | L27 | 1.62e-03 | 13 | 87 | 2 | SM00569 | |
| Domain | L27 | 1.62e-03 | 13 | 87 | 2 | PS51022 | |
| Domain | L27_dom | 1.62e-03 | 13 | 87 | 2 | IPR004172 | |
| Domain | KRAB | 1.67e-03 | 369 | 87 | 7 | SM00349 | |
| Domain | KRAB | 1.70e-03 | 370 | 87 | 7 | IPR001909 | |
| Domain | PDZ | 4.27e-03 | 141 | 87 | 4 | PF00595 | |
| Domain | PDZ | 5.07e-03 | 148 | 87 | 4 | SM00228 | |
| Domain | zf-CCHC | 5.09e-03 | 23 | 87 | 2 | PF00098 | |
| Domain | - | 5.31e-03 | 150 | 87 | 4 | 2.30.42.10 | |
| Domain | C2H2_Znf_fam | 5.54e-03 | 24 | 87 | 2 | IPR027775 | |
| Domain | - | 6.48e-03 | 26 | 87 | 2 | 4.10.60.10 | |
| Domain | Bromodomain_CS | 6.48e-03 | 26 | 87 | 2 | IPR018359 | |
| Pubmed | 6.91e-14 | 21 | 90 | 7 | 12216073 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 ARID1B REXO4 TAF3 ILF3 MAP4 RBBP6 RBM19 AHNAK U2SURP CAST NUP98 LARP1 NCL TAF1 CDK11B IK SSX1 SSX2 TAF1L | 3.98e-13 | 954 | 90 | 20 | 36373674 |
| Pubmed | 1.30e-11 | 9 | 90 | 5 | 14611804 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NOLC1 REXO4 ILF3 AKAP8 MAP4 RBBP6 RBM19 U2SURP ZCRB1 WDR46 RPS15 LARP1 NCL CDK11B CMSS1 RBM47 MSI2 | 2.67e-11 | 807 | 90 | 17 | 22681889 |
| Pubmed | NOLC1 KIFAP3 REXO4 ILF3 AKAP8 RBBP6 RBM19 MORF4L1 ZCRB1 RPS15 RBM42 LARP1 NCL RBM47 MSI2 | 5.49e-10 | 723 | 90 | 15 | 34133714 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZSCAN29 NOLC1 ESYT2 ILF3 AKAP8 RBBP6 AHNAK MORF4L1 U2SURP RBPJ NUP98 RBM42 NCL REST MTREX IK TAF1L BHLHE40 KAT14 | 7.12e-10 | 1294 | 90 | 19 | 30804502 |
| Pubmed | 2.91e-09 | 8 | 90 | 4 | 12007189 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NOLC1 ILF3 MAP4 ACLY RBM19 AHNAK MORF4L1 U2SURP CAST RPS15 LARP1 AK2 NCL MTREX CMSS1 IK WNK1 AHNAK2 MSI2 | 3.09e-09 | 1415 | 90 | 19 | 28515276 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 REXO4 ILF3 AKAP8 MAP4 RBBP6 ACLY RBM19 AHNAK NUP98 RPS15 LARP1 NCL MTREX CMSS1 IK PATJ ITIH2 | 3.17e-09 | 1257 | 90 | 18 | 36526897 |
| Pubmed | ILF3 AKAP8 RBBP6 U2SURP ZCRB1 RPS15 RBM42 LARP1 NCL CDK11B MTREX CMSS1 IK MSI2 | 4.39e-09 | 713 | 90 | 14 | 29802200 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOLC1 REXO4 ILF3 AKAP8 ACLY RBM19 AHNAK MORF4L1 U2SURP WDR46 RPS15 NCL CDK11B MTREX CMSS1 IK | 4.86e-09 | 989 | 90 | 16 | 36424410 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | REXO4 ILF3 AKAP8 MAP4 ACLY RBM19 AHNAK WDR46 CAST LARP1 FAM83D IK AKAP12 AHNAK2 | 5.33e-09 | 724 | 90 | 14 | 36232890 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | NOLC1 REXO4 ILF3 AKAP8 RBM19 U2SURP RPS15 LARP1 NCL BCL11A CDK11B MTREX IK | 5.68e-09 | 605 | 90 | 13 | 28977666 |
| Pubmed | NOLC1 REXO4 ILF3 MAP4 RBBP6 U2SURP RPS15 RBM42 LARP1 NCL MTREX CMSS1 IK MSI2 | 6.02e-09 | 731 | 90 | 14 | 29298432 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 ESYT2 TAF3 ILF3 AKAP8 MAP4 RBBP6 ACLY CAST NUP98 LARP1 NCL CDK11B REST | 1.23e-08 | 774 | 90 | 14 | 15302935 |
| Pubmed | NOLC1 REXO4 MAP4 ACLY AHNAK U2SURP WDR46 NUP98 RPS15 LARP1 NCL MTREX IK | 1.40e-08 | 653 | 90 | 13 | 22586326 | |
| Pubmed | SSX2-4 expression in early-stage non-small cell lung cancer. | 1.68e-08 | 3 | 90 | 3 | 24645645 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ZSCAN29 NOLC1 ARID1B REXO4 TAF3 ILF3 AKAP8 MAP6 RBBP6 MORF4L1 U2SURP RBM42 NCL CDK11B IK UNC13A | 1.71e-08 | 1082 | 90 | 16 | 38697112 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 ILF3 MAP4 RBBP6 ACLY AHNAK U2SURP CAST NUP98 LARP1 AK2 NCL WNK1 AKAP12 AHNAK2 | 1.71e-08 | 934 | 90 | 15 | 33916271 |
| Pubmed | ARID1B TAF3 MAP4 RBBP6 ACLY AHNAK CAST LARP1 TAF1 PEAK1 IK PATJ | 1.90e-08 | 549 | 90 | 12 | 38280479 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | REXO4 ILF3 AKAP8 RBBP6 RBM19 U2SURP RPS15 RBM42 LARP1 NCL MTREX CMSS1 MSI2 | 2.18e-08 | 678 | 90 | 13 | 30209976 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 ESYT2 AMER1 AKAP8 MAP4 AHNAK LARP1 FNIP1 PEAK1 MTREX PATJ WNK1 C6orf132 AHNAK2 | 4.63e-08 | 861 | 90 | 14 | 36931259 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 5.47e-08 | 283 | 90 | 9 | 30585729 | |
| Pubmed | Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas. | 6.69e-08 | 4 | 90 | 3 | 12037676 | |
| Pubmed | REXO4 TAF3 ILF3 AKAP8 MAP4 ACLY RBM19 AHNAK RBM42 LARP1 NCL CDK11B MTREX CMSS1 RBM47 ITIH2 MSI2 | 7.45e-08 | 1371 | 90 | 17 | 36244648 | |
| Pubmed | NOLC1 ARID1B AMER1 MAP4 MAP6 CTC1 RBPJ CAST PEAK1 IK NCOA4 PATJ WNK1 ZFP37 AKAP12 | 1.19e-07 | 1084 | 90 | 15 | 11544199 | |
| Pubmed | 1.24e-07 | 223 | 90 | 8 | 20020773 | ||
| Pubmed | NOLC1 ESYT2 ILF3 AKAP8 MAP4 RBBP6 U2SURP NUP98 RPS15 LARP1 NCL MSI2 | 1.29e-07 | 655 | 90 | 12 | 35819319 | |
| Pubmed | NOLC1 TSHZ3 ARID1B REXO4 TAF3 AKAP8 RBBP6 MORF4L1 RBPJ NUP98 RPS15 LARP1 BCL11A TAF1 TAF1L KAT14 MSI2 | 1.34e-07 | 1429 | 90 | 17 | 35140242 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOLC1 ILF3 MAP4 RBBP6 ACLY AHNAK U2SURP WDR46 RPS15 LARP1 NCL CDK11B CMSS1 IK | 1.52e-07 | 949 | 90 | 14 | 36574265 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ARID1B ILF3 ACLY AHNAK PCLO RPS15 LARP1 AK2 NCL PEAK1 SPAG17 HYDIN AHNAK2 | 1.63e-07 | 807 | 90 | 13 | 30575818 |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.68e-07 | 232 | 90 | 8 | 25515538 | |
| Pubmed | 1.75e-07 | 156 | 90 | 7 | 22952844 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NOLC1 ESYT2 TAF3 ILF3 MAP4 RBBP6 ACLY AHNAK U2SURP WDR46 NUP98 RPS15 LARP1 NCL CDK11B MTREX | 2.53e-07 | 1318 | 90 | 16 | 30463901 |
| Pubmed | 3.95e-07 | 469 | 90 | 10 | 27634302 | ||
| Pubmed | 5.94e-07 | 274 | 90 | 8 | 34244482 | ||
| Pubmed | NOLC1 AMER1 ILF3 MAP4 RBBP6 ACLY U2SURP NUP98 RPS15 LARP1 FAM83D NCL MTREX IK PATJ | 7.05e-07 | 1247 | 90 | 15 | 27684187 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOLC1 REXO4 ILF3 MAP4 ACLY RBM19 PCLO U2SURP RBPJ WDR46 NUP98 LARP1 NCL PEAK1 MTREX IK | 7.12e-07 | 1425 | 90 | 16 | 30948266 |
| Pubmed | 7.45e-07 | 503 | 90 | 10 | 16964243 | ||
| Pubmed | NOLC1 AMER1 ILF3 TCERG1L AHNAK SPEF2 PCLO U2SURP NUP98 RBM42 ANKRD30A LARP1 ANKRD30B NCL SPAG17 JSRP1 | 8.32e-07 | 1442 | 90 | 16 | 35575683 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 8.45e-07 | 123 | 90 | 6 | 26912792 | |
| Pubmed | 1.15e-06 | 407 | 90 | 9 | 15772651 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.17e-06 | 130 | 90 | 6 | 35545047 | |
| Pubmed | ESYT2 REXO4 AKAP8 MAP4 RBBP6 RBM19 MORF4L1 RPS15 RBM42 FAM83D MTREX CMSS1 IK PATJ TAF1L C6orf132 | 1.36e-06 | 1497 | 90 | 16 | 31527615 | |
| Pubmed | 1.39e-06 | 9 | 90 | 3 | 12665565 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ILF3 AKAP8 MAP4 ACLY AHNAK U2SURP CAST RPS15 LARP1 AK2 NCL PATJ AKAP12 MSI2 | 1.49e-06 | 1149 | 90 | 14 | 35446349 |
| Pubmed | 1.52e-06 | 421 | 90 | 9 | 34650049 | ||
| Pubmed | 1.93e-06 | 223 | 90 | 7 | 33731348 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOLC1 REXO4 ILF3 MAP4 ACLY RBM19 AHNAK U2SURP WDR46 RPS15 NCL MTREX CMSS1 IK AHNAK2 | 1.94e-06 | 1353 | 90 | 15 | 29467282 |
| Pubmed | 2.23e-06 | 441 | 90 | 9 | 31239290 | ||
| Pubmed | 2.97e-06 | 340 | 90 | 8 | 24332808 | ||
| Pubmed | 3.45e-06 | 347 | 90 | 8 | 16033648 | ||
| Pubmed | 3.67e-06 | 469 | 90 | 9 | 37314180 | ||
| Pubmed | 4.21e-06 | 251 | 90 | 7 | 31076518 | ||
| Pubmed | 4.66e-06 | 483 | 90 | 9 | 36912080 | ||
| Pubmed | 5.58e-06 | 494 | 90 | 9 | 26831064 | ||
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 6.00e-06 | 265 | 90 | 7 | 19240061 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 6.53e-06 | 175 | 90 | 6 | 25756610 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 6.62e-06 | 269 | 90 | 7 | 29511261 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 24710929 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 31545650 | ||
| Pubmed | A novel fluorescence in situ hybridization assay for synovial sarcoma. | 6.62e-06 | 2 | 90 | 2 | 23623359 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 38804708 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 15735574 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 15007166 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 10070062 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20833135 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 22842574 | ||
| Pubmed | [Analysis of SYT/SSX1 and SYT/SSX2 fusion genes from synovial sarcoma]. | 6.62e-06 | 2 | 90 | 2 | 22393780 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 27571988 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 34403156 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 11280766 | ||
| Pubmed | 7.55e-06 | 653 | 90 | 10 | 33742100 | ||
| Pubmed | ILF3 AKAP8 MAP4 MORF4L1 CAST RPS15 RBM42 LARP1 NCL MTREX CMSS1 MSI2 | 7.78e-06 | 971 | 90 | 12 | 33306668 | |
| Pubmed | KIFAP3 ESYT2 AMER1 ILF3 MAP4 ACLY AHNAK U2SURP RPS15 LARP1 NCL | 7.90e-06 | 809 | 90 | 11 | 32129710 | |
| Pubmed | ARID1B ILF3 MAP4 ACLY SCN1A ZCRB1 RPS15 LARP1 NCL CDK11B REST MTREX MSI2 | 8.43e-06 | 1153 | 90 | 13 | 29845934 | |
| Pubmed | 8.55e-06 | 106 | 90 | 5 | 12429849 | ||
| Pubmed | 8.96e-06 | 107 | 90 | 5 | 11347906 | ||
| Pubmed | NOLC1 TAF3 ILF3 MAP4 RBBP6 AHNAK NUP98 NCL TAF1 CDK11B MTREX IK | 1.20e-05 | 1014 | 90 | 12 | 32416067 | |
| Pubmed | 1.20e-05 | 295 | 90 | 7 | 26209609 | ||
| Pubmed | REXO4 ILF3 AKAP8 RBBP6 U2SURP NUP98 RPS15 LARP1 NCL MTREX IK | 1.21e-05 | 847 | 90 | 11 | 35850772 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOLC1 ILF3 AKAP8 MAP4 ACLY AHNAK U2SURP WDR46 NUP98 NCL MTREX IK | 1.32e-05 | 1024 | 90 | 12 | 24711643 |
| Pubmed | 1.33e-05 | 551 | 90 | 9 | 34728620 | ||
| Pubmed | 1.51e-05 | 425 | 90 | 8 | 21081503 | ||
| Pubmed | 1.65e-05 | 206 | 90 | 6 | 34185411 | ||
| Pubmed | 1.83e-05 | 124 | 90 | 5 | 20850016 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 1.88e-05 | 316 | 90 | 7 | 31665637 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.93e-05 | 440 | 90 | 8 | 34244565 | |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 1.94e-05 | 212 | 90 | 6 | 33462405 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 16822332 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 7539744 | ||
| Pubmed | Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases. | 1.98e-05 | 3 | 90 | 2 | 22976541 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 22080784 | ||
| Pubmed | TAFII55 binding to TAFII250 inhibits its acetyltransferase activity. | 1.98e-05 | 3 | 90 | 2 | 11592977 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 21940993 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 24130893 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 12217962 | ||
| Pubmed | TAF7: a possible transcription initiation check-point regulator. | 1.98e-05 | 3 | 90 | 2 | 16407123 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 7655467 | ||
| Pubmed | Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma. | 1.98e-05 | 3 | 90 | 2 | 16152617 | |
| Interaction | RPL31 interactions | NOLC1 MSX2 REXO4 TAF3 ILF3 RBM19 U2SURP ZCRB1 RPS15 RBM42 LARP1 NCL TAF1 REST MTREX CMSS1 IK | 5.13e-09 | 680 | 88 | 17 | int:RPL31 |
| Interaction | SMC5 interactions | NOLC1 ARID1B REXO4 TAF3 ILF3 MAP4 RBBP6 RBM19 AHNAK U2SURP CAST NUP98 LARP1 NCL TAF1 CDK11B IK SSX1 SSX2 TAF1L | 8.39e-09 | 1000 | 88 | 20 | int:SMC5 |
| Interaction | DDX21 interactions | MSX2 REXO4 ILF3 AKAP8 RBM19 U2SURP ZCRB1 WDR46 RPS15 RBM42 LARP1 NCL REST MTREX IK | 4.63e-07 | 718 | 88 | 15 | int:DDX21 |
| Interaction | CHD4 interactions | NOLC1 TSHZ3 REXO4 ILF3 AKAP8 RBBP6 RBM19 AHNAK U2SURP RBPJ RPS15 LARP1 NCL BCL11A CDK11B MTREX IK | 5.30e-07 | 938 | 88 | 17 | int:CHD4 |
| Interaction | SRSF5 interactions | REXO4 ILF3 RBM19 U2SURP ZCRB1 WDR46 RPS15 LARP1 NCL REST CMSS1 IK | 1.01e-06 | 474 | 88 | 12 | int:SRSF5 |
| Interaction | RSL1D1 interactions | NOLC1 H1-8 REXO4 ILF3 RBM19 U2SURP ZCRB1 WDR46 CAST RPS15 NCL CMSS1 | 1.13e-06 | 479 | 88 | 12 | int:RSL1D1 |
| Interaction | H1-1 interactions | H1-8 REXO4 ILF3 RBM19 PCLO U2SURP ZCRB1 RPS15 LARP1 NCL TAF1 CDK11B | 2.04e-06 | 507 | 88 | 12 | int:H1-1 |
| Interaction | LLPH interactions | 2.54e-06 | 139 | 88 | 7 | int:LLPH | |
| Interaction | RRS1 interactions | 2.62e-06 | 345 | 88 | 10 | int:RRS1 | |
| Interaction | RPS14 interactions | NOLC1 H1-8 REXO4 ILF3 MAP4 RBBP6 RBM19 RPS15 RBM42 LARP1 NCL REST | 3.17e-06 | 529 | 88 | 12 | int:RPS14 |
| Interaction | EFTUD2 interactions | NOLC1 ILF3 MAP4 ACLY RBM19 AHNAK MORF4L1 U2SURP CAST RPS15 RBM42 LARP1 AK2 NCL MTREX CMSS1 IK WNK1 AHNAK2 MSI2 | 3.25e-06 | 1449 | 88 | 20 | int:EFTUD2 |
| Interaction | RNF2 interactions | NOLC1 ILF3 AKAP8 PCLO MORF4L1 WDR46 RPS15 LARP1 NCL CDK11B REST IK SSX2 RBM47 MSI2 | 4.71e-06 | 866 | 88 | 15 | int:RNF2 |
| Interaction | CHD3 interactions | NOLC1 REXO4 ILF3 AKAP8 U2SURP RBPJ RPS15 LARP1 NCL BCL11A TAF1 MTREX IK BHLHE40 | 4.83e-06 | 757 | 88 | 14 | int:CHD3 |
| Interaction | H1-4 interactions | NOLC1 MSX2 REXO4 ILF3 RBM19 U2SURP ZCRB1 RPS15 LARP1 NCL CDK11B CMSS1 SPAG17 | 5.21e-06 | 656 | 88 | 13 | int:H1-4 |
| Interaction | RPS6 interactions | NOLC1 H1-8 REXO4 ILF3 RBM19 PCLO ZCRB1 WDR46 RPS15 RBM42 LARP1 NCL REST CMSS1 RBM47 | 5.27e-06 | 874 | 88 | 15 | int:RPS6 |
| Interaction | RPS2 interactions | ESYT2 ILF3 MAP4 ACLY RBM19 U2SURP ZCRB1 RPS15 RBM42 LARP1 NCL REST RBM47 | 5.30e-06 | 657 | 88 | 13 | int:RPS2 |
| Interaction | RPL35 interactions | MSX2 REXO4 ILF3 RBM19 U2SURP ZCRB1 WDR46 RPS15 RBM42 LARP1 NCL REST | 5.46e-06 | 558 | 88 | 12 | int:RPL35 |
| Interaction | ZNF346 interactions | 5.75e-06 | 377 | 88 | 10 | int:ZNF346 | |
| Interaction | KRR1 interactions | 6.02e-06 | 379 | 88 | 10 | int:KRR1 | |
| Interaction | RPL17 interactions | H1-8 REXO4 ILF3 RBM19 ZCRB1 RPS15 RBM42 LARP1 NCL CDK11B REST RBM47 | 6.89e-06 | 571 | 88 | 12 | int:RPL17 |
| Interaction | H1-6 interactions | 7.24e-06 | 229 | 88 | 8 | int:H1-6 | |
| Interaction | DDX23 interactions | NOLC1 KIFAP3 REXO4 TAF3 RBBP6 RBM19 U2SURP RBM42 NCL TAF1 IK | 7.66e-06 | 480 | 88 | 11 | int:DDX23 |
| Interaction | OBSL1 interactions | NOLC1 ILF3 ACLY RBM19 AHNAK PCLO U2SURP WDR46 NUP98 RBM42 FNIP1 NCL MTREX CMSS1 IK | 7.69e-06 | 902 | 88 | 15 | int:OBSL1 |
| Interaction | FGF8 interactions | 7.81e-06 | 108 | 88 | 6 | int:FGF8 | |
| Interaction | H2AC17 interactions | 7.96e-06 | 232 | 88 | 8 | int:H2AC17 | |
| Interaction | RNF113A interactions | NOLC1 ESYT2 ILF3 AKAP8 MAP4 RBBP6 U2SURP NUP98 RPS15 LARP1 NCL IK MSI2 | 9.25e-06 | 692 | 88 | 13 | int:RNF113A |
| Interaction | CEBPB interactions | NOLC1 TSHZ3 ILF3 AKAP8 MAP4 ACLY AHNAK U2SURP CAST NUP98 RPS15 RBM42 LARP1 AK2 NCL MTREX IK BHLHE40 MSI2 | 1.18e-05 | 1443 | 88 | 19 | int:CEBPB |
| Interaction | CIT interactions | ZSCAN29 NOLC1 ILF3 RBBP6 RBM19 AHNAK PCLO NUP98 RPS15 RBM42 LARP1 NCL MTREX IK PATJ SPAG17 RBM47 C6orf132 AHNAK2 | 1.27e-05 | 1450 | 88 | 19 | int:CIT |
| Interaction | SSX7 interactions | 1.29e-05 | 11 | 88 | 3 | int:SSX7 | |
| Interaction | H2BC5 interactions | 1.43e-05 | 331 | 88 | 9 | int:H2BC5 | |
| Interaction | GRK5 interactions | 1.50e-05 | 182 | 88 | 7 | int:GRK5 | |
| Interaction | NUP43 interactions | ARID1B REXO4 TAF3 MAP4 RBBP6 RBM19 NUP98 LARP1 AK2 CCDC168 CDK11B AHNAK2 | 1.70e-05 | 625 | 88 | 12 | int:NUP43 |
| Interaction | RPL27 interactions | 1.84e-05 | 431 | 88 | 10 | int:RPL27 | |
| Interaction | NIFK interactions | 1.84e-05 | 431 | 88 | 10 | int:NIFK | |
| Interaction | REXO4 interactions | 1.87e-05 | 261 | 88 | 8 | int:REXO4 | |
| Interaction | SIRT7 interactions | NOLC1 REXO4 MAP4 ACLY AHNAK U2SURP WDR46 NUP98 RPS15 LARP1 NCL MTREX IK | 1.99e-05 | 744 | 88 | 13 | int:SIRT7 |
| Interaction | NAA40 interactions | NOLC1 ILF3 MAP4 RBBP6 ACLY AHNAK U2SURP CAST NUP98 LARP1 AK2 NCL WNK1 AKAP12 AHNAK2 | 2.00e-05 | 978 | 88 | 15 | int:NAA40 |
| Interaction | RPS19 interactions | REXO4 ILF3 PER2 RBM19 U2SURP ZCRB1 RPS15 RBM42 LARP1 NCL REST CMSS1 | 2.12e-05 | 639 | 88 | 12 | int:RPS19 |
| Interaction | MYCN interactions | NOLC1 ARID1B REXO4 ILF3 AKAP8 RBBP6 ACLY RBM19 U2SURP ZCRB1 RPS15 RBM42 LARP1 NCL MTREX CMSS1 IK MSI2 | 2.23e-05 | 1373 | 88 | 18 | int:MYCN |
| Interaction | ZC3H18 interactions | NOLC1 REXO4 ILF3 MAP4 RBBP6 U2SURP RPS15 RBM42 LARP1 NCL MTREX CMSS1 IK MSI2 | 2.53e-05 | 877 | 88 | 14 | int:ZC3H18 |
| Interaction | ZCRB1 interactions | 2.68e-05 | 134 | 88 | 6 | int:ZCRB1 | |
| Interaction | NEIL1 interactions | 2.79e-05 | 276 | 88 | 8 | int:NEIL1 | |
| Interaction | MDM2 interactions | NOLC1 REXO4 ILF3 PER2 RBBP6 RPS15 NCL TAF1 REST MTREX CMSS1 MSI2 | 2.82e-05 | 658 | 88 | 12 | int:MDM2 |
| Interaction | BTRC interactions | NOLC1 AMER1 ILF3 AKAP8 PER2 RBM19 SCN1A LARP1 FNIP1 NCL REST BHLHE40 MSI2 | 3.05e-05 | 775 | 88 | 13 | int:BTRC |
| Interaction | RC3H2 interactions | REXO4 ILF3 AKAP8 RBBP6 RBM19 U2SURP RPS15 LARP1 NCL MTREX RBM47 MSI2 | 3.22e-05 | 667 | 88 | 12 | int:RC3H2 |
| Interaction | H1-5 interactions | 3.39e-05 | 463 | 88 | 10 | int:H1-5 | |
| Interaction | MECP2 interactions | ZSCAN29 NOLC1 ARID1B REXO4 TAF3 ILF3 AKAP8 MAP6 RBBP6 MORF4L1 U2SURP RBPJ RBM42 NCL CDK11B IK UNC13A | 3.57e-05 | 1287 | 88 | 17 | int:MECP2 |
| Interaction | PABPC5 interactions | 3.71e-05 | 142 | 88 | 6 | int:PABPC5 | |
| Interaction | RC3H1 interactions | REXO4 ILF3 RBM19 U2SURP RPS15 RBM42 LARP1 NCL MTREX CMSS1 RBM47 MSI2 | 3.72e-05 | 677 | 88 | 12 | int:RC3H1 |
| Interaction | RPL7A interactions | NOLC1 MSX2 H1-8 REXO4 ILF3 RBM19 ZCRB1 WDR46 RPS15 RBM42 NCL REST | 3.83e-05 | 679 | 88 | 12 | int:RPL7A |
| Interaction | LIN28B interactions | 4.23e-05 | 214 | 88 | 7 | int:LIN28B | |
| Interaction | KIF20A interactions | NOLC1 ILF3 AKAP8 RBBP6 RBM19 AHNAK PCLO NUP98 RPS15 LARP1 FAM83D NCL IK AHNAK2 MSI2 | 4.65e-05 | 1052 | 88 | 15 | int:KIF20A |
| Interaction | PABPC1 interactions | MSX2 ILF3 MAP4 AHNAK CAST RBM42 LARP1 NCL REST MTREX RBM47 MSI2 | 5.07e-05 | 699 | 88 | 12 | int:PABPC1 |
| Interaction | PURG interactions | 5.49e-05 | 223 | 88 | 7 | int:PURG | |
| Interaction | ARRDC3 interactions | 5.65e-05 | 224 | 88 | 7 | int:ARRDC3 | |
| Interaction | TAF4 interactions | 6.27e-05 | 156 | 88 | 6 | int:TAF4 | |
| Interaction | SRSF6 interactions | REXO4 RBBP6 RBM19 U2SURP ZCRB1 WDR46 RPS15 LARP1 CDK11B REST | 6.78e-05 | 503 | 88 | 10 | int:SRSF6 |
| Interaction | RPS3 interactions | MSX2 H1-8 ILF3 ACLY RBM19 U2SURP ZCRB1 RPS15 RBM42 LARP1 NCL REST | 6.83e-05 | 721 | 88 | 12 | int:RPS3 |
| Interaction | PRC1 interactions | NOLC1 ILF3 AKAP8 RBBP6 AHNAK WDR46 NUP98 RPS15 LARP1 NCL CMSS1 IK PATJ UNC13A | 7.79e-05 | 973 | 88 | 14 | int:PRC1 |
| Interaction | GLDC interactions | 8.08e-05 | 321 | 88 | 8 | int:GLDC | |
| Interaction | H2BC12 interactions | 8.26e-05 | 322 | 88 | 8 | int:H2BC12 | |
| Interaction | SNRNP70 interactions | ILF3 AKAP8 RBBP6 U2SURP ZCRB1 RPS15 RBM42 LARP1 NCL CDK11B MTREX CMSS1 IK MSI2 | 8.78e-05 | 984 | 88 | 14 | int:SNRNP70 |
| Interaction | LARP7 interactions | NOLC1 REXO4 ILF3 ACLY RBM19 SCN1A U2SURP ZCRB1 RPS15 RBM42 LARP1 NCL CDK11B CMSS1 MSI2 | 8.78e-05 | 1113 | 88 | 15 | int:LARP7 |
| Interaction | RPL26 interactions | 8.93e-05 | 419 | 88 | 9 | int:RPL26 | |
| Interaction | JSRP1 interactions | 1.01e-04 | 21 | 88 | 3 | int:JSRP1 | |
| Interaction | PRR3 interactions | 1.02e-04 | 246 | 88 | 7 | int:PRR3 | |
| Interaction | RPS24 interactions | 1.03e-04 | 529 | 88 | 10 | int:RPS24 | |
| Interaction | H2AB2 interactions | 1.06e-04 | 107 | 88 | 5 | int:H2AB2 | |
| Interaction | FMR1 interactions | 1.15e-04 | 536 | 88 | 10 | int:FMR1 | |
| Interaction | RPS8 interactions | MSX2 REXO4 ILF3 RBM19 U2SURP ZCRB1 RPS15 RBM42 LARP1 NCL REST | 1.20e-04 | 649 | 88 | 11 | int:RPS8 |
| Interaction | TPT1 interactions | 1.33e-04 | 345 | 88 | 8 | int:TPT1 | |
| Interaction | FGFBP1 interactions | 1.33e-04 | 257 | 88 | 7 | int:FGFBP1 | |
| Interaction | H1-7 interactions | 1.34e-04 | 179 | 88 | 6 | int:H1-7 | |
| Interaction | H3C1 interactions | KIFAP3 REXO4 TAF3 AHNAK U2SURP RBPJ WDR46 CAST LARP1 TAF1 IK KAT14 ITIH2 | 1.40e-04 | 901 | 88 | 13 | int:H3C1 |
| Interaction | MEN1 interactions | NOLC1 ARID1B REXO4 ILF3 AKAP8 RBBP6 U2SURP WDR46 NUP98 RPS15 LARP1 TAF1 MTREX IK | 1.41e-04 | 1029 | 88 | 14 | int:MEN1 |
| Interaction | ZNF22 interactions | 1.43e-04 | 114 | 88 | 5 | int:ZNF22 | |
| Interaction | MAGEB2 interactions | 1.44e-04 | 349 | 88 | 8 | int:MAGEB2 | |
| Interaction | FGF13 interactions | 1.61e-04 | 117 | 88 | 5 | int:FGF13 | |
| Interaction | TRIM31 interactions | 1.63e-04 | 454 | 88 | 9 | int:TRIM31 | |
| Interaction | AGR2 interactions | ARID1B ILF3 ACLY AHNAK PCLO RPS15 LARP1 AK2 NCL PEAK1 SPAG17 HYDIN AHNAK2 | 2.00e-04 | 934 | 88 | 13 | int:AGR2 |
| Interaction | NPM1 interactions | REXO4 TAF3 ILF3 RBM19 NUP98 RPS15 RBM42 HEMGN ANKRD30A LARP1 NCL REST CMSS1 AKAP12 AHNAK2 | 2.03e-04 | 1201 | 88 | 15 | int:NPM1 |
| Interaction | TNIP1 interactions | NOLC1 ILF3 MAP4 RBBP6 ACLY AHNAK MORF4L1 U2SURP WDR46 RPS15 LARP1 NCL CDK11B CMSS1 IK | 2.34e-04 | 1217 | 88 | 15 | int:TNIP1 |
| Interaction | RPL13A interactions | 2.52e-04 | 591 | 88 | 10 | int:RPL13A | |
| Interaction | YBX2 interactions | 2.73e-04 | 289 | 88 | 7 | int:YBX2 | |
| Interaction | IFI16 interactions | REXO4 ILF3 ACLY RBM19 U2SURP WDR46 NUP98 LARP1 NCL CDK11B MTREX | 2.74e-04 | 714 | 88 | 11 | int:IFI16 |
| Interaction | USP36 interactions | 2.81e-04 | 599 | 88 | 10 | int:USP36 | |
| Interaction | ADARB1 interactions | 2.83e-04 | 489 | 88 | 9 | int:ADARB1 | |
| Interaction | RPS13 interactions | 2.83e-04 | 489 | 88 | 9 | int:RPS13 | |
| Interaction | H1-3 interactions | 2.85e-04 | 291 | 88 | 7 | int:H1-3 | |
| Interaction | FBXO32 interactions | 2.85e-04 | 386 | 88 | 8 | int:FBXO32 | |
| Interaction | YWHAH interactions | NOLC1 ESYT2 AMER1 ILF3 AKAP8 AHNAK LARP1 FNIP1 PEAK1 MTREX PATJ WNK1 C6orf132 AHNAK2 | 2.86e-04 | 1102 | 88 | 14 | int:YWHAH |
| Interaction | RBM45 interactions | 2.94e-04 | 207 | 88 | 6 | int:RBM45 | |
| Interaction | RPL23A interactions | 3.08e-04 | 606 | 88 | 10 | int:RPL23A | |
| Interaction | RPS16 interactions | ILF3 RBM19 C1orf87 U2SURP ZCRB1 RPS15 RBM42 LARP1 NCL REST CMSS1 | 3.08e-04 | 724 | 88 | 11 | int:RPS16 |
| Interaction | RPL37A interactions | 3.11e-04 | 391 | 88 | 8 | int:RPL37A | |
| Interaction | H2AB3 interactions | 3.25e-04 | 136 | 88 | 5 | int:H2AB3 | |
| Interaction | CDC5L interactions | NOLC1 ILF3 AKAP8 RBBP6 AHNAK MORF4L1 U2SURP RPS15 RBM42 NCL MTREX IK | 3.33e-04 | 855 | 88 | 12 | int:CDC5L |
| Interaction | NR2C2 interactions | NOLC1 ESYT2 TAF3 ILF3 MAP4 RBBP6 ACLY AHNAK U2SURP WDR46 NUP98 RPS15 LARP1 NCL CDK11B MTREX | 3.41e-04 | 1403 | 88 | 16 | int:NR2C2 |
| Interaction | SRSF4 interactions | 3.42e-04 | 300 | 88 | 7 | int:SRSF4 | |
| Interaction | DHX15 interactions | 3.43e-04 | 502 | 88 | 9 | int:DHX15 | |
| Cytoband | Xp11.23 | 3.62e-08 | 95 | 90 | 6 | Xp11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp11 | 9.91e-06 | 377 | 90 | 7 | chrXp11 | |
| GeneFamily | RNA binding motif containing | 2.13e-06 | 213 | 51 | 7 | 725 | |
| GeneFamily | PDZ domain containing | 6.76e-05 | 152 | 51 | 5 | 1220 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 3.02e-03 | 29 | 51 | 2 | 396 | |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP | 5.99e-07 | 89 | 89 | 6 | M2761 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1 | 7.51e-07 | 6 | 89 | 3 | M5931 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN | 1.02e-05 | 407 | 89 | 9 | M2214 | |
| Coexpression | MUELLER_METHYLATED_IN_GLIOBLASTOMA | 1.39e-05 | 43 | 89 | 4 | M912 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 1.64e-05 | 432 | 89 | 9 | M41149 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | ARID1B AKAP8 CTC1 ACLY MORF4L1 RBPJ TAF1 CDK11B TAF1L BHLHE40 | 2.31e-05 | 568 | 89 | 10 | MM3824 |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 6.68e-05 | 295 | 89 | 7 | M39121 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.27e-06 | 200 | 90 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-05 | 144 | 90 | 5 | 57d2846ec26d4490ec11c171af447b17a729437e | |
| ToppCell | Ciliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.46e-05 | 170 | 90 | 5 | 8b7ef1464ea589886b575ebad5447b085cbdcdba | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.69e-05 | 185 | 90 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.78e-05 | 186 | 90 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.78e-05 | 186 | 90 | 5 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.29e-05 | 191 | 90 | 5 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 4.29e-05 | 191 | 90 | 5 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.29e-05 | 191 | 90 | 5 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.29e-05 | 191 | 90 | 5 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class (2021.01.30) | 4.29e-05 | 191 | 90 | 5 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.29e-05 | 191 | 90 | 5 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 4.29e-05 | 191 | 90 | 5 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | ASK428-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.40e-05 | 192 | 90 | 5 | 356ebddd03aec341b79890977edb8ff0804999a1 | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.51e-05 | 193 | 90 | 5 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.62e-05 | 194 | 90 | 5 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-05 | 194 | 90 | 5 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.62e-05 | 194 | 90 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.62e-05 | 194 | 90 | 5 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 4.74e-05 | 195 | 90 | 5 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.74e-05 | 195 | 90 | 5 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.74e-05 | 195 | 90 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.74e-05 | 195 | 90 | 5 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.74e-05 | 195 | 90 | 5 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.74e-05 | 195 | 90 | 5 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 4.85e-05 | 196 | 90 | 5 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-05 | 196 | 90 | 5 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 4.85e-05 | 196 | 90 | 5 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.97e-05 | 197 | 90 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 197 | 90 | 5 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 197 | 90 | 5 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 197 | 90 | 5 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 197 | 90 | 5 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 4.97e-05 | 197 | 90 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.09e-05 | 198 | 90 | 5 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.22e-05 | 199 | 90 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 5.22e-05 | 199 | 90 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 90 | 5 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 90 | 5 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 90 | 5 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 90 | 5 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | H1299|World / Cell line, Condition and Strain | 5.34e-05 | 200 | 90 | 5 | 23f08d7cffacfced48785cd3ad230ecadb95713f | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Tfr.Ctps_(Ctps)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.88e-04 | 55 | 90 | 3 | 0b62b4f438a493a30bddb99e1eadd20c92704ee9 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.88e-04 | 55 | 90 | 3 | fa556ea954ea868a4b23e410f3b27d69e04794ee | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Krt80|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.92e-04 | 141 | 90 | 4 | 40ef6d792e11fe10963d64eb0b606b90556c1a70 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-04 | 143 | 90 | 4 | ce045ec7c311a1797ae562bec114f9e90604d063 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-04 | 150 | 90 | 4 | b6f1fc62d08199fed6156c7cd32f66d9926531b5 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.43e-04 | 150 | 90 | 4 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.49e-04 | 151 | 90 | 4 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.62e-04 | 153 | 90 | 4 | 151c469b26f9adf04dd6f117f03bef760cc3d45d | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.68e-04 | 154 | 90 | 4 | a90c4c45685eae8d21d03479cfd5a23f6ed3ca07 | |
| ToppCell | Control-PLT_4|World / Disease Group and Platelet Clusters | 2.68e-04 | 154 | 90 | 4 | a2a03c5e6759c45aeeedf1e68ecb5a0112ef9a20 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.03e-04 | 159 | 90 | 4 | 5543f5aec6352a7c5923e55daf3ed40ff5cc0f0c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 159 | 90 | 4 | d2de9391b00b6c47f5fe28a1bad6da2097107ee0 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 159 | 90 | 4 | da6b7f8039adc19839d6c090a0b3d68fb6445a79 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-04 | 160 | 90 | 4 | 398f162e8a75c6cb5c3e4d1832e98d386e1f222b | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-04 | 160 | 90 | 4 | 12aaab0291035f578e2433efd169ae72f393a5a5 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-04 | 163 | 90 | 4 | 2e1c1193c04620cc187b1567dfba025beef1e4e1 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 164 | 90 | 4 | 9fed5df40f50bde35db8bf89c291cbdc0e104112 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 164 | 90 | 4 | e712d6b89461f741dbd773ba9a27ecaddf97cbaa | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.41e-04 | 164 | 90 | 4 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.41e-04 | 164 | 90 | 4 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.57e-04 | 166 | 90 | 4 | 52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.73e-04 | 168 | 90 | 4 | 99148986aa5628f67d85258c171b254be77a071c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.82e-04 | 169 | 90 | 4 | f06118754fa62c580b4bcbecff6f9e5fdc2106a0 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.17e-04 | 173 | 90 | 4 | a809be2630d2b91b53b82b5e2bb99e05524597c1 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 174 | 90 | 4 | f230d23618a6487f2664efb2c677e0a4559e2bf4 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.26e-04 | 174 | 90 | 4 | cfb4947caf7b1a856df246023fc6e5bfcc97ad36 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 176 | 90 | 4 | ed788a5969edfd1199828ca5b0dd34e7f29c4d30 | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.45e-04 | 176 | 90 | 4 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_early_2|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.45e-04 | 176 | 90 | 4 | 8e0ac3ad5e47614b4befabd674a40e3eaae553f3 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.54e-04 | 177 | 90 | 4 | 3cfde67b93f3986312f5e74e42504214d966e7dc | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.54e-04 | 177 | 90 | 4 | 12a52a12a87a31e501ced611f46a90d172ca7e35 | |
| ToppCell | B_cell_maturation-CD34+_pre-plamsa|World / Lineage and Cell class | 4.54e-04 | 177 | 90 | 4 | 3ff06100deee9bee852a52078666999a9f7beaf1 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.54e-04 | 177 | 90 | 4 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | (06)_Krt4/13+|World / shred by cell type and Timepoint | 4.64e-04 | 178 | 90 | 4 | 46efdf03aa1317bc600138e871509b995e773cce | |
| ToppCell | RSV-Healthy-4|RSV / Virus stimulation, Condition and Cluster | 4.64e-04 | 178 | 90 | 4 | a5835951492c051443f3c30d45f9a7b1b2557477 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 178 | 90 | 4 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | RSV-Healthy-4|Healthy / Virus stimulation, Condition and Cluster | 4.64e-04 | 178 | 90 | 4 | a6d71aebb5c462311f8ade24f659642b6b329633 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.74e-04 | 179 | 90 | 4 | d4efbc34f52136039b96451fd0b0a0ad164197c6 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.74e-04 | 179 | 90 | 4 | 8a66d197a2f55d763ff7ef0bec89ee96f59c3937 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.84e-04 | 180 | 90 | 4 | 557453b74d4a9cc95ed1c7b9a9a58e45eb02ed6a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-04 | 180 | 90 | 4 | adf5db5bfa9a38b1227ab0beccd8d6f3eea67ac0 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-04 | 180 | 90 | 4 | cf6e9f757afeb342c5023f6e6152a1b4d0d164b4 | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.84e-04 | 180 | 90 | 4 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.84e-04 | 180 | 90 | 4 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.05e-04 | 182 | 90 | 4 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 5.05e-04 | 182 | 90 | 4 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.15e-04 | 183 | 90 | 4 | d23018193b9c0806e0d1a9ac15e6392eb8e96aaf | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-04 | 184 | 90 | 4 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-04 | 184 | 90 | 4 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.37e-04 | 185 | 90 | 4 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.37e-04 | 185 | 90 | 4 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 5.37e-04 | 185 | 90 | 4 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 5.37e-04 | 185 | 90 | 4 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-04 | 186 | 90 | 4 | 4dce1484653bb266e2305cbb306fb11eaf7892e2 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9 | 5.48e-04 | 186 | 90 | 4 | e8580a2093eb7e50aad55ec7fada850d2fed8ae1 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.48e-04 | 186 | 90 | 4 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.48e-04 | 186 | 90 | 4 | 708c5edefe36c91df27cf53c1b5101fb2030cc5a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.48e-04 | 186 | 90 | 4 | 029390c4aaf64e6bcd86124cd4a6dd2e6f3a374b | |
| Drug | DB01888 | 8.46e-07 | 19 | 90 | 4 | CID005287990 | |
| Drug | bromfenacoum | NOLC1 KIFAP3 TAF3 MAP4 MAP6 ACLY AHNAK CAST NUP98 LARP1 NCL IK PATJ | 1.46e-06 | 644 | 90 | 13 | ctd:C013418 |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.02e-05 | 189 | 90 | 7 | 2231_UP | |
| Drug | 1-EBIO | 1.36e-05 | 37 | 90 | 4 | CID000082320 | |
| Disease | parietal cortex measurement, white matter microstructure measurement | 7.44e-06 | 2 | 81 | 2 | EFO_0005674, EFO_0008420 | |
| Disease | synovial sarcoma | 1.11e-04 | 6 | 81 | 2 | C0039101 | |
| Disease | pulse pressure measurement | TGFBR3 ARID1B GLT8D1 TTBK1 MORF4L1 RPS15 HRH1 CDK11B CMSS1 IK HYDIN MSI2 | 4.02e-04 | 1392 | 81 | 12 | EFO_0005763 |
| Disease | Metastatic melanoma | 4.47e-04 | 54 | 81 | 3 | C0278883 | |
| Disease | cardiotoxicity, response to anthracycline-based chemotherapy | 6.63e-04 | 14 | 81 | 2 | EFO_0005257, EFO_1001482 | |
| Disease | response to acetylsalicylate | 8.71e-04 | 16 | 81 | 2 | GO_1903492 | |
| Disease | Cannabis use, age at onset | 1.23e-03 | 19 | 81 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | Malignant neoplasm of breast | 2.71e-03 | 1074 | 81 | 9 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PDMAKVAPKPATPDK | 396 | Q9UPW8 | |
| SDKPGMEEKAQPPEA | 711 | A0FGR8 | |
| MSKAVAPGDKPKIQE | 1071 | P04920 | |
| PEKPSAFKPAVEMQK | 526 | Q9BXX2 | |
| PKPLPMPSNSEDKKD | 331 | Q2NKJ3 | |
| LMEKETAKPKPDPFK | 451 | O43823 | |
| EMKGSVEEPKPEEPK | 656 | Q02952 | |
| PSDPAPKVMDFKEKP | 191 | O14503 | |
| PKVMDFKEKPSSPAK | 196 | O14503 | |
| KDMQTFKAEPPGKPS | 626 | Q9BXX3 | |
| EPKPGLPEDLQKLMK | 86 | Q9BQ75 | |
| KGPDVKLPDMSVKTP | 681 | Q09666 | |
| TEKAVAEKFPSMPKP | 151 | Q5JTC6 | |
| SPPATEKMACKDPEK | 246 | Q5JTC6 | |
| LLSKPGDEDDAPPKM | 261 | Q8NFD5 | |
| PAPAQKPAQLKEEKM | 256 | P21127 | |
| PTGKNEKKAPAPPME | 396 | Q8N0U7 | |
| APQKKKLQDTPSEPM | 666 | Q9Y4C8 | |
| MALEVPEPLGEDKKK | 336 | Q9BTD8 | |
| FPAAPAPKMIEDGKI | 456 | A0AV96 | |
| ECKKAQPKEVMFPPG | 181 | Q96DH6 | |
| EEQKKPMKNKPGPYS | 276 | Q14978 | |
| KSETKDPPATPMQKL | 621 | Q17RG1 | |
| MAPKQDPKPKFQEGE | 1 | Q9UBU8 | |
| PQKEPVEKGSAQMDP | 596 | Q13127 | |
| PPKKDMKEQEKGEGS | 201 | Q6PKG0 | |
| NPMSDPKKKEERLKP | 521 | P52948 | |
| SGEARKVPPKPDKAM | 211 | Q8IZA3 | |
| PSKDMGPPKENKKET | 366 | P27816 | |
| APSKDMGPPKENKIV | 391 | P27816 | |
| MGPPKENKIVPAKDL | 396 | P27816 | |
| KNQAPMVPAPVKDEG | 571 | Q96JE9 | |
| IEMTADGKPPVQKKD | 2256 | Q5T1H1 | |
| GPSVDTRPKKMEKEP | 56 | Q96MG2 | |
| PGKDPEKPEASMEVK | 876 | P19823 | |
| KSEPKGVPVQKKPEM | 2051 | Q6PRD1 | |
| FNPPKEPMKDDITGE | 156 | P54819 | |
| VDKPPSPSPIEMKKA | 81 | Q9H165 | |
| TNPPAEKKAVPAMEK | 546 | O15055 | |
| KAPVADDKPKQPKMV | 746 | Q9Y6V0 | |
| DDKPKQPKMVKPTTD | 751 | Q9Y6V0 | |
| PGNPGDSKDMKEIEP | 371 | Q9H792 | |
| HNKPPTMKPEGEKLS | 206 | Q9H8E8 | |
| PRKADLDPEMPAEGK | 341 | Q9H4H8 | |
| LDPEMPAEGKAERKP | 346 | Q9H4H8 | |
| MIQSDKGADPPDKKD | 1 | Q96JB8 | |
| KVKEDPDQGESMKPL | 136 | Q68CQ7 | |
| FPQEMKEKPKEEPGI | 451 | Q9BXL5 | |
| QGDPKKMAPPPKEVE | 11 | P19338 | |
| VKPSPKRKMEPDTEK | 1176 | Q7Z6E9 | |
| GKDKNGMPVEPKPEP | 436 | Q13772 | |
| MAEKDSGPAGQPEKP | 706 | Q5T0Z8 | |
| GKQGPIKEEPPMKKS | 2366 | Q4G0P3 | |
| GMVVEKKPPDKIVPA | 726 | Q8TF40 | |
| SKMPKKPKNENPVDY | 341 | Q12906 | |
| ADPEDGKPVMDKVKE | 446 | P20810 | |
| NMVEGEGAPKKKEPQ | 256 | Q9UH90 | |
| YDPMGNKKEPEKLPD | 96 | Q96LR7 | |
| PENPKGDAKKPGKES | 241 | P35367 | |
| QMKDPDPCKSGSEPK | 2011 | Q8NDH2 | |
| KSSKPKDPPPFEGME | 111 | Q92845 | |
| PFSVEALMSDKKPPK | 46 | P35548 | |
| NKKETSPQVKGEEMP | 106 | Q9GZR2 | |
| KGREDKMKAPAPPLV | 641 | Q5VWG9 | |
| KENQPADPKEKSPQM | 1281 | Q9C093 | |
| EDKKPKGKSPPMAEA | 1311 | Q9C093 | |
| PVPMQKEGAGEKEPS | 226 | Q9NP31 | |
| EKEIKNEPMNSSGPK | 1006 | Q14DG7 | |
| PPGPMKKDKDQDAIT | 161 | Q8IZX4 | |
| PPPGPMKKDKDQDSI | 161 | P21675 | |
| IMPKKPAEEGNVSKE | 111 | Q99909 | |
| IMPKKPAEDENDSKG | 111 | Q16384 | |
| DKRPKDFPQGKENPM | 2186 | Q6Q759 | |
| NPKPDKKDDDENGPK | 36 | P35498 | |
| APMLPPPKNKEDFEK | 396 | O15042 | |
| ADEVAPAKKAKPAMP | 461 | P53396 | |
| MPSFKVPKVDLKGPE | 1416 | Q8IVF2 | |
| MPSFKVPKVDLKGPE | 2241 | Q8IVF2 | |
| KSRDGDKEDKEPPPM | 306 | Q5VWI1 | |
| RKAKKEAPPMEKPEV | 61 | P62841 | |
| PGDMKKSPVTAELAP | 841 | Q5TCY1 | |
| KPAKPDEKGEMQVVP | 716 | P42285 | |
| GISPKIMPKKPAEEG | 106 | Q16385 | |
| EKKEKRQGTAPPPMK | 1186 | Q8NI35 | |
| FPKMVPGDSKSEGKP | 21 | A6NEH6 | |
| IMPKKPAEEENGLKE | 111 | O60224 | |
| IMPKKPAEEGNDSKG | 111 | Q7RTT5 | |
| IMPKKPAEEGNDSKG | 111 | Q7RTT4 | |
| IMPKKPAEVGNDSKE | 111 | Q7RTT3 | |
| KPKVDDEPMDVDKGP | 386 | Q13123 | |
| METAPKPGKDVPPKK | 1 | O15213 | |
| EKMKEPDGKLSPPKR | 626 | Q63HK5 | |
| TPCPKEPNKEMINDG | 311 | Q06330 | |
| PKNMLGEREPPKKKE | 121 | Q8TBF4 | |
| TGDSDPQPAPKKMKT | 36 | Q9NS25 | |
| KKEGPVASPPFMDLE | 1971 | Q9H4A3 | |
| LGPQEQMNPKEKLKP | 156 | Q8IWY8 | |
| PKPDMISKLEKGEAP | 76 | Q9Y6Q3 | |
| SKEKGPSMKEPNPIS | 761 | Q03167 |